• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYBERONICS, INC. LEAD MODEL 302

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYBERONICS, INC. LEAD MODEL 302 Back to Search Results
Model Number 302-20
Device Problem High impedance (1291)
Patient Problem Pain (1994)
Event Date 01/30/2016
Event Type  malfunction  
Event Description
It was reported that the patient铠lead experienced high impedance.He was scheduled for a full revision surgery.The patient also reported painful stimulation in the neck, and the device was disabled in relation to the high lead impedance.Surgery has not been reported to occur to date.Additional pertinent information has not been received to date.
 
Event Description
The patient's vns system was fully replaced on (b)(6) 2016.The impedance value of the replacement system was within normal limits.The explanting facility does not return explanted devices, so product return of the explanted generator or lead is not expected.No additional pertinent information has been received to date.
 
Event Description
The explanted generator and lead portion were received and underwent product analysis.It was noted that the lead was still inserted into the generator when it was received.A continuity check was performed on the lead and setscrew of the generator which verified proper contact between the lead pin and setscrew.Analysis on the lead found a kink in the lead coils however no discontinuities were identified in the returned portion of the lead.It was noted the portion of the lead with the electrode segment was not returned.Therefore it could not be evaluated and its role in the reported high impedance could not be determined.During analysis on the generator various impedance loads were attached to the generator and the subsequent diagnostic tests resulted in the accurate resistance measurements in all instances.The generator found that it performed to functional specification.The internal data of the generator was reviewed and noted the last >25% change in impedance occurred on (b)(6) 2016 when the prechange value was 2460 ohms and the postchange value was 11807 ohms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 302
Type of Device
LEAD
Manufacturer (Section D)
CYBERONICS, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
CYBERONICS, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key5639498
MDR Text Key46080644
Report Number1644487-2016-00976
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 04/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/30/2004
Device Model Number302-20
Device Lot Number7416
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/26/2016
Is the Reporter a Health Professional? Yes
Event Location Other
Initial Date Manufacturer Received 04/13/2016
Initial Date FDA Received05/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received05/31/2016
11/18/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/26/2002
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age40 YR
-
-